Ref ID: 15888
Author:
Michael Praseuth1, Antonia Gallo2,
Scott E. Baker3 , Clay C. C. Wang1, and Kenneth S. Bruno3
Author address:
Department of Pharmacology and Pharmaceutical Sciences, University of Southern California,
School of Pharmacy, Los Angeles, California, USA. 3Chemical and Biological Process Development Group, Energy and Environment Directorate, Pacific
Northwest N
Full conference title:
26th Fungal Genetics Conference
Date: 15 March 2014
Abstract:
Interest in natural products produced by fungi has grown substantially in recent years. Available genome sequences of filamentous fungi have revealed
that these organisms contain the capacity to produce far more secondary metabolites than previously identified by conventional analysis. In large part,
the reason that these compounds remain uncharacterized is due to the lack of gene expression under typical laboratory conditions. One approach to
identifying novel compounds produced by fungi is heterologous expression of predicted secondary metabolite genes in a tractable model organism such
as Aspergillus nidulans. Although this has proved successful with some compounds, an analysis in the native organism could prove more fruitful in
determining all of the enzymes necessary to produce a given compound. For this reason we have developed a transformation protocol for transformation
in Aspergillus carbonarious strain ITEM 5010. We have successfully deleted the kusA orthologue in this strain using the hygromycin phosphotransferase
marker. In a subsequent transformation we deleted the orthologue of an Aspergillus niger gene responsible for naptha-pyrone production. Gene deletion
and overexpression will be used to identify genes responsible for production of secondary metabolites in this species.
Abstract Number: NULL
Conference Year: 2011
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a